Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Jamba, Inc. Announces Changes to Its Senior Management Team
Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen.
- General Nutrition Centers, Inc. Reports Second Quarter 2008 Financial Results
General Nutrition Centers, Inc. has announced FY08Q2 results, with reported revenues of $422.7 million, an 8.5% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 6.3%; Franchise by 8.6%; and Manufacturing/Wholesale by 28.0%. Same store sales improved 4.5% in domestic company-owned stores (including internet sales), and 5.2% in Canadian stores
- General Nutrition Centers, Inc. Reports Second Quarter 2008 Financial Results
General Nutrition Centers, Inc. has announced FY08Q2 results, with reported revenues of $422.7 million, an 8.5% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 6.3%; Franchise by 8.6%; and Manufacturing/Wholesale by 28.0%. Same store sales improved 4.5% in domestic company-owned stores (including internet sales), and 5.2% in Canadian stores
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Senomyx Announces Second Quarter 2008 Financial Results
Senomyx has announced FY08Q2 results, reporting Q2 revenues of $9.6 million for the six months ended June 30, 2008, compared to $6.8 million for the six months ended June 30, 2007.
- Senomyx Announces Second Quarter 2008 Financial Results
Senomyx has announced FY08Q2 results, reporting Q2 revenues of $9.6 million for the six months ended June 30, 2008, compared to $6.8 million for the six months ended June 30, 2007.
- ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million.
- ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million.
- ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million.
- Omega Protein Reports Second Quarter Results
Omega Protein Corporation has announced FY08Q2 results, reporting a Q2 income of $6.7 million ($0.37 per share) with a net income of $2.5 million ($0.15 per share) for the second quater of the previous year.
- Omega Protein Reports Second Quarter Results
Omega Protein Corporation has announced FY08Q2 results, reporting a Q2 income of $6.7 million ($0.37 per share) with a net income of $2.5 million ($0.15 per share) for the second quater of the previous year.
- Omega Protein Reports Second Quarter Results
Omega Protein Corporation has announced FY08Q2 results, reporting a Q2 income of $6.7 million ($0.37 per share) with a net income of $2.5 million ($0.15 per share) for the second quater of the previous year.
- NutraCea Announces Second Quarter 2008 Financial Results
NutraCea (NTRZ) has announced FY08 Q2 results, reporting net revenues of $10.3 million for the second quarter of 2008, compared to net revenues of $13.0 million for the second quarter of 2007, with a one-time license fee of $5.0 million (non-recurring) without which net revenues for the second quarter 2007 would have been $8,000,000. Net loss for the second quarter of 2008 was $6.1 million, or $(0.04) per share, compared to net income of $2.0 million or $0.01 per share for the same period last year.
- NutraCea Announces Second Quarter 2008 Financial Results
NutraCea (NTRZ) has announced FY08 Q2 results, reporting net revenues of $10.3 million for the second quarter of 2008, compared to net revenues of $13.0 million for the second quarter of 2007, with a one-time license fee of $5.0 million (non-recurring) without which net revenues for the second quarter 2007 would have been $8,000,000. Net loss for the second quarter of 2008 was $6.1 million, or $(0.04) per share, compared to net income of $2.0 million or $0.01 per share for the same period last year.
- KI NutriCare to Acquire Allergy Research Group for $1.33 Per Share in an All Cash Tender Offer Valued at Approximately $19,500,000
KI NutriCare, Inc. and Allergy Research Group, Inc. (ALRG) have announced that KI NutriCare, a wholly-owned subsidiary of Kikkoman Corporation (TSE:2801), Longhorn Acquisition Corp., a wholly-owned subsidiary of KI NutriCare formed to effect the transaction, and Allergy Research Group have entered into a definitive agreement pursuant to which Allergy Research Group will be acquired for approximately $19,500,000 through an all cash tender offer of $1.33 per share by Longhorn Acquisition Corp.
- KI NutriCare to Acquire Allergy Research Group for $1.33 Per Share in an All Cash Tender Offer Valued at Approximately $19,500,000
KI NutriCare, Inc. and Allergy Research Group, Inc. (ALRG) have announced that KI NutriCare, a wholly-owned subsidiary of Kikkoman Corporation (TSE:2801), Longhorn Acquisition Corp., a wholly-owned subsidiary of KI NutriCare formed to effect the transaction, and Allergy Research Group have entered into a definitive agreement pursuant to which Allergy Research Group will be acquired for approximately $19,500,000 through an all cash tender offer of $1.33 per share by Longhorn Acquisition Corp.
- Synutra Achieved 88.7% Net Sales Growth for the First Quarter Ended June 30, 2008
Company reports Q1 net sales in the first quarter ended June 30, 2008 increased by 88.7% to $127.4 million, compared to $67.5 million for the same quarter in 2007. First quarter net income increased by 193.0% to $15.6 million, compared to net income of $5.3 million in the same period in 2007. Synutra earned $0.29 per share (basic) in the first quarter of fiscal 2008, up 163.6% from $0.11 earned in the prior year period.
- Synutra Achieved 88.7% Net Sales Growth for the First Quarter Ended June 30, 2008
Company reports Q1 net sales in the first quarter ended June 30, 2008 increased by 88.7% to $127.4 million, compared to $67.5 million for the same quarter in 2007. First quarter net income increased by 193.0% to $15.6 million, compared to net income of $5.3 million in the same period in 2007. Synutra earned $0.29 per share (basic) in the first quarter of fiscal 2008, up 163.6% from $0.11 earned in the prior year period.
- Schiff Nutrition International, Inc. Announces Fiscal 2008 Fourth Quarter and Year-End Results
Schiff Nutrition International, Inc., has announced FY08 Q4 results reporting net sales were $50.4 million for the three months ended May 31, 2008, compared to $43.2 million for the same period in fiscal 2007. For the fiscal 2008 fourth quarter, Schiff Nutrition reported net income of $2.8 million, or $0.10 per diluted share, compared to net income of $3.7 million, or $0.13 per diluted share, for the same period a year ago. Schiff Nutrition's net sales were $176.9 million for the year ended May 31, 2008, compared to $172.7 million for fiscal 2007. For fiscal 2008, Schiff Nutrition reported net income of $11.3 million, or $0.40 per diluted share, compared to net income of $12.4 million, or $0.45 per diluted share, for fiscal 2007.
- Schiff Nutrition International, Inc. Announces Fiscal 2008 Fourth Quarter and Year-End Results
Schiff Nutrition International, Inc., has announced FY08 Q4 results reporting net sales were $50.4 million for the three months ended May 31, 2008, compared to $43.2 million for the same period in fiscal 2007. For the fiscal 2008 fourth quarter, Schiff Nutrition reported net income of $2.8 million, or $0.10 per diluted share, compared to net income of $3.7 million, or $0.13 per diluted share, for the same period a year ago. Schiff Nutrition's net sales were $176.9 million for the year ended May 31, 2008, compared to $172.7 million for fiscal 2007. For fiscal 2008, Schiff Nutrition reported net income of $11.3 million, or $0.40 per diluted share, compared to net income of $12.4 million, or $0.45 per diluted share, for fiscal 2007.
- Frutarom Second Quarter 2008 Results Release Scheduled for Tuesday, August 19, 2008
Frutarom announced that it will be releasing its second quarter 2008 results on Tuesday, August 19, 2008.
The Company will also be hosting a conference call on the same day at 2:00pm UK time or 9:00am EDT. During the call, management will review and discuss the results and will be available to answer investor questions.
- Frutarom Second Quarter 2008 Results Release Scheduled for Tuesday, August 19, 2008
Frutarom announced that it will be releasing its second quarter 2008 results on Tuesday, August 19, 2008.
The Company will also be hosting a conference call on the same day at 2:00pm UK time or 9:00am EDT. During the call, management will review and discuss the results and will be available to answer investor questions.
- Balchem Corporation's New Choline Memor-C Website Goes Live
Balchem Corporation today announced its Food, Pharma and Nutrition segment has launched a new website to provide information on its food grade Choline product line, Memor-C(tm), for food fortification.
- Balchem Corporation's New Choline Memor-C Website Goes Live
Balchem Corporation today announced its Food, Pharma and Nutrition segment has launched a new website to provide information on its food grade Choline product line, Memor-C(tm), for food fortification.
- Balchem Corporation's New Choline Memor-C Website Goes Live
Balchem Corporation today announced its Food, Pharma and Nutrition segment has launched a new website to provide information on its food grade Choline product line, Memor-C(tm), for food fortification.
- Forbes Medi-Tech Announces Second Quarter 2008 Financial Results
Forbes Medi-Tech Inc. today announced its results for the second quarter 2008 ended June 30, 2008. Comparative period for these statements is the three- and six-month periods ended June 30, 2007. Forbes reiterates its financial outlook for the full year 2008 and continues to expect sales of $9.75 million to $10.5 million, an increase of up to 18% compared to its reported revenues in 2007.
- Forbes Medi-Tech Announces Second Quarter 2008 Financial Results
Forbes Medi-Tech Inc. today announced its results for the second quarter 2008 ended June 30, 2008. Comparative period for these statements is the three- and six-month periods ended June 30, 2007. Forbes reiterates its financial outlook for the full year 2008 and continues to expect sales of $9.75 million to $10.5 million, an increase of up to 18% compared to its reported revenues in 2007.
- Galaxy Nutritional Foods Reports First Quarter Operating Results
Galaxy Nutritional Foods, Inc. has announced its FY08 Q1 results, reporting income from operations of $227,689 and net income of $119,951, or $0.01 per basic and diluted share, on net sales of approximately $6 million. In the prior-year quarter ended June 30, 2007, the Company reported net income of $150,999, or $0.01 per basic and diluted share, on net sales of approximately $5.9 million.
- Galaxy Nutritional Foods Reports First Quarter Operating Results
Galaxy Nutritional Foods, Inc. has announced its FY08 Q1 results, reporting income from operations of $227,689 and net income of $119,951, or $0.01 per basic and diluted share, on net sales of approximately $6 million. In the prior-year quarter ended June 30, 2007, the Company reported net income of $150,999, or $0.01 per basic and diluted share, on net sales of approximately $5.9 million.
- AIBMR Celebrates its 30th Anniversary
AIBMR Life Sciences, Inc. is celebrating its 30th year of service in the neutraceutical industry, servicing over 600 companies in the US and abroad.
- AIBMR Celebrates its 30th Anniversary
AIBMR Life Sciences, Inc. is celebrating its 30th year of service in the neutraceutical industry, servicing over 600 companies in the US and abroad.
- CV Technologies Reports Third Quarter Results
CV Technologies has released its FY08 Q3 results, reporting third quarter sales of $3.4 million, up 4.4% from sales of $3.2 million in the same quarter last year. The net loss was $2.0 million or $0.02 of net loss per share in the third quarter ended June 30, 2008, compared to a net loss of $1.9 million or $0.02 of net loss per share in the comparable period last year.
- CV Technologies Reports Third Quarter Results
CV Technologies has released its FY08 Q3 results, reporting third quarter sales of $3.4 million, up 4.4% from sales of $3.2 million in the same quarter last year. The net loss was $2.0 million or $0.02 of net loss per share in the third quarter ended June 30, 2008, compared to a net loss of $1.9 million or $0.02 of net loss per share in the comparable period last year.
- GLG Life Tech Corporation Announces Q2 2008 Results
GLG Life Tech Corporation has announced its FY08 Q2 results, reporting that revenues for the second quarter ending June 30, 2008 were $1,238,893, a decrease of 4.5% from $1,297,344 in revenue for the second quarter in 2007. Stevia revenue was $1,091,720 for the second quarter in 2008, a marginal decrease from $1,093,863 in the second quarter 2007.
- GLG Life Tech Corporation Announces Q2 2008 Results
GLG Life Tech Corporation has announced its FY08 Q2 results, reporting that revenues for the second quarter ending June 30, 2008 were $1,238,893, a decrease of 4.5% from $1,297,344 in revenue for the second quarter in 2007. Stevia revenue was $1,091,720 for the second quarter in 2008, a marginal decrease from $1,093,863 in the second quarter 2007.
- GLG Life Tech Corporation Announces Q2 2008 Results
GLG Life Tech Corporation has announced its FY08 Q2 results, reporting that revenues for the second quarter ending June 30, 2008 were $1,238,893, a decrease of 4.5% from $1,297,344 in revenue for the second quarter in 2007. Stevia revenue was $1,091,720 for the second quarter in 2008, a marginal decrease from $1,093,863 in the second quarter 2007.
- Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Tiens Biotech Group (USA), Inc., announced financial results for the second quarter and six months ended June 30, 2008. The company reports that for the second quarter ended June 30, 2008, revenue was $19.7 million, an increase of 37.2% compared to $14.3 million for the same period in 2007. Net income for the second quarter of 2008 was $4.6 million, compared to net income of $5.0 million for the second quarter of 2007. Earnings per share for the second quarter of each of 2008 and 2007 were $0.07. For the six months ended June 30, 2008, revenue was $32.5 million, an increase of 6.3% compared to $30.6 million for the same period in 2007.
- Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Tiens Biotech Group (USA), Inc., announced financial results for the second quarter and six months ended June 30, 2008. The company reports that for the second quarter ended June 30, 2008, revenue was $19.7 million, an increase of 37.2% compared to $14.3 million for the same period in 2007. Net income for the second quarter of 2008 was $4.6 million, compared to net income of $5.0 million for the second quarter of 2007. Earnings per share for the second quarter of each of 2008 and 2007 were $0.07. For the six months ended June 30, 2008, revenue was $32.5 million, an increase of 6.3% compared to $30.6 million for the same period in 2007.
- Lifeway Foods Reports Record Q2 and First Half 2008 Results
Lifeway Foods, Inc. has announced their FY08 Q2 results, reporting sales increased 19% to approximately $11,523,500 from $9,715,000 during the same period a year ago. Second quarter 2008 gross profit virtually unchanged to $3,872,569 from $3,829,076 during the same period a year ago. Gross margins were 34% in the second quarter 2008. Operating income was $1,546,161 for the second quarter 2008. Net Income was $911,718 for the second quarter 2008. Earnings per share were $.05 per share for the second quarter 2008.
- Lifeway Foods Reports Record Q2 and First Half 2008 Results
Lifeway Foods, Inc. has announced their FY08 Q2 results, reporting sales increased 19% to approximately $11,523,500 from $9,715,000 during the same period a year ago. Second quarter 2008 gross profit virtually unchanged to $3,872,569 from $3,829,076 during the same period a year ago. Gross margins were 34% in the second quarter 2008. Operating income was $1,546,161 for the second quarter 2008. Net Income was $911,718 for the second quarter 2008. Earnings per share were $.05 per share for the second quarter 2008.
- Fytokem announces reinstatement of trading on TSX Venture Exchange
Fytokem Products Inc. has announced that common shares in the capital of the Company will be reinstated for trading on the TSX Venture Exchange effective the opening Thursday, August 14, 2008.
- Fytokem announces reinstatement of trading on TSX Venture Exchange
Fytokem Products Inc. has announced that common shares in the capital of the Company will be reinstated for trading on the TSX Venture Exchange effective the opening Thursday, August 14, 2008.
- Fytokem announces reinstatement of trading on TSX Venture Exchange
Fytokem Products Inc. has announced that common shares in the capital of the Company will be reinstated for trading on the TSX Venture Exchange effective the opening Thursday, August 14, 2008.
- Cyanotech Reports Financial Results for the First Quarter of Fiscal 2009
Cyanotech Corporation has announced FY09 Q1 results, reporting revenues of $3,701,000, compared to revenues of $2,583,000 for the first quarter of fiscal 2008. Gross profit for the quarter was $1,304,000, with gross profit margin of 35%, compared to a gross profit of $746,000 and gross profit margin of 29% reported for the same quarter prior year. Net income for the first quarter was $271,000, or $0.05 per diluted share, compared to net loss of $382,000, or ($0.07) per diluted share for the first quarter of fiscal 2008.
- Cyanotech Reports Financial Results for the First Quarter of Fiscal 2009
Cyanotech Corporation has announced FY09 Q1 results, reporting revenues of $3,701,000, compared to revenues of $2,583,000 for the first quarter of fiscal 2008. Gross profit for the quarter was $1,304,000, with gross profit margin of 35%, compared to a gross profit of $746,000 and gross profit margin of 29% reported for the same quarter prior year. Net income for the first quarter was $271,000, or $0.05 per diluted share, compared to net loss of $382,000, or ($0.07) per diluted share for the first quarter of fiscal 2008.
- NPRI Offers Free Freight
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight Until September 15, 2008
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight Until September 15, 2008
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight Until September 15, 2008
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- NPRI Offers Free Freight Until September 15, 2008
Nutri Pharmaceuticals Research, Inc. is offering to reimburse customers for half the cost of their freight shipping, up to a limit of $200 until September 15, 2008.
- BI Nutraceuticals Names Raymond Signore East Coast Regional Sales Manager
BI Nutraceuticals has hired Raymond Signore as an East Coast Regional Sales Manager. Signore will be responsible for supporting and expanding BI's strong position with East Coast customers, as well as growing the company's customer base within the region.
- BI Nutraceuticals Names Raymond Signore East Coast Regional Sales Manager
BI Nutraceuticals has hired Raymond Signore as an East Coast Regional Sales Manager. Signore will be responsible for supporting and expanding BI's strong position with East Coast customers, as well as growing the company's customer base within the region.
- BI Nutraceuticals Names Raymond Signore East Coast Regional Sales Manager
BI Nutraceuticals has hired Raymond Signore as an East Coast Regional Sales Manager. Signore will be responsible for supporting and expanding BI's strong position with East Coast customers, as well as growing the company's customer base within the region.
- BI Nutraceuticals Names Raymond Signore East Coast Regional Sales Manager
BI Nutraceuticals has hired Raymond Signore as an East Coast Regional Sales Manager. Signore will be responsible for supporting and expanding BI's strong position with East Coast customers, as well as growing the company's customer base within the region.
- Frutarom Presents Second Quarter Results
Frutarom USA Inc., has announced FY08 Q2 results, reporting income of US$ 132 million, reflecting growth of 44.6% compared with the same quarter in 2007 (growth of 36% excluding the influence of the revaluation of the European currencies compared with the US dollar). In the first half of 2008, Frutarom's sales totaled US$ 254.6 million - growth of 47.8% compared with the parallel quarter in 2007.
- Frutarom Presents Second Quarter Results
Frutarom USA Inc., has announced FY08 Q2 results, reporting income of US$ 132 million, reflecting growth of 44.6% compared with the same quarter in 2007 (growth of 36% excluding the influence of the revaluation of the European currencies compared with the US dollar). In the first half of 2008, Frutarom's sales totaled US$ 254.6 million - growth of 47.8% compared with the parallel quarter in 2007.
- NOW® Top Selling Supplement Brand According to SPINS
SPINS, a source of information regarding natural products, has named NOW Foods as the top selling nutritional supplement brand within the natural supermarket channel for the year ending on July 12, 2008.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
ISI Brands, Inc./Twinlab(R) and renowned pediatrician Dr. Alan Greene have teamed with leading national health retailer The Vitamin Shoppe for the retail launch of Twinlab DrGreene(TM) line of nutritional supplements, it was announced today by Mark Fox, President, ISI Brands/Twinlab and Tony Truesdale, President of The Vitamin Shoppe.
The Vitamin Shoppe will debut the Dr. Greene nutritional supplement product line in mid-August, 2008 and will be celebrated with launch events in Vitamin Shoppe stores in San Francisco, New York, and Los Angeles. The products will be available exclusively in the more than 360 Vitamin Shoppe stores across the U.S. as well as on-line at vitaminshoppe.com during August, before expanding to other retail outlets.
Taking a completely new approach to the marketplace, the DrGreene(TM) system of supplements support the nutritional requirements of pre-expectant and pregnant women, nursing mothers, toddlers and growing children, creating a strong foundation for a lifetime of health.
For the pregnant woman, Twinlab's (R) DrGreene(TM) product line provides the nutrients needed to optimize health during this stressful time on her body. For toddlers and growing children, the DrGreene(TM) supplements provide all the recommended and important nutrients they need to develop, grow strong, and maintain an active life -- including life'sDHA(TM), a vegetarian DHA found in the Toddler Drops which has been shown to support brain and eye development.
"Children are overfed and undernourished," observes Dr. Greene, the nationally renowned pediatrician. "Children may be eating more, but in many cases they're not getting the nutrition they need. The supplements we've developed help mothers give the gift of a nutritional head start to their children by providing the right nutrients at the right time -- whether its during pregnancy, breastfeeding, or beyond, as the baby grows and develops past infancy and through childhood," said Dr. Greene.
The Twinlab(R) DrGreene(TM) line is unique in that it is designed to be used even before the time when a woman might conceive, through pregnancy and lactation, toddler and childhood. "The earlier a woman of childbearing age starts supplementation with our prenatal products, the better," remarks Dr. Greene. "The mother is carrying the eggs that will become her child, even when she herself is born, so in this respect caring nutritionally for the baby-to-be starts much earlier than most people realize." The system is comprised initially of six products: Product Description ------------------------- ------------------------------------------------ Dr. Greene(TM) Prenatal Specifically formulated with 22 nutrients and a gentle source of iron for the unique needs of women who might conceive or are already pregnant or lactating. Dr. Greene(TM) Pre/Post A blend of calcium, magnesium and vitamin D at Natal Bone Support the right ratios helps cover the demands of what the baby takes from the mother's system for development and growth. Dr. Greene(TM) Pre/Post Incredibly important for healthy development, Natal Omega-3 our micro-distilled Omega-3s supply a blend of DHA (to support baby's brain and eye growth) and EPA (for healthy joint function and cardiovascular health). Dr. Greene(TM) Toddler Drops This unique liquid multivitamin fills a common gap in many children's nutritional development -- after breastfeeding, but before they can take a chewable multivitamin/mineral. Infused with life'sDHA(TM), a plant-derived form of DHA found in breast milk and all quality infant formulas, this formula provides many of the nutrients required for this especially demanding time of developing body and mind. For ages 1-3 years. Dr. Greene(TM) Children's Packed with vitamins and minerals, these Chewable Multivitamin/ chewable tablets provide a healthy way to get Multimineral the nutritional insurance children need without the artificial flavors, colors, added (Two products: Orange, preservatives or sweeteners found in many of the Berry) "cartoon" vitamins on shelves today. For ages 4 and up.
Reflecting Dr. Greene's celebrated philosophy, the formulas contain only natural colors and flavors, and have no high fructose corn syrup or added preservatives. Even the packaging remains true to Dr. Greene's commitment to preserving the environment, as only eco-friendly and recycled materials are utilized for all elements of the packaging, including adhesives, labels and cartons with post consumer fibers.
"We are very excited to be joining with The Vitamin Shoppe in launching the first product line under our new partnership with Dr. Greene," said Mark Fox. "The Vitamin Shoppe is one of the country's most trusted resources for health, and Dr. Greene is nationally recognized for his commitment to families and growing children. The Twinlab(R) Dr. Greene(TM) supplements reflect Dr. Greene's commitment to the utmost in quality health and wellness products and our company's mission to provide customers with premium quality wellness solutions for every stage of life."
"The Twinlab(R) DrGreene(TM) products are a welcome addition to the new and innovative products found at The Vitamin Shoppe," said Tony Truesdale, President and Chief Merchandising Officer of The Vitamin Shoppe. "We're pleased to be launching the DrGreen products first at The Vitamin Shoppe. We are confident they will become an important supplemental product line for moms as they seek to ensure the utmost in nutritional balance for their families."
A father of four, Dr. Greene is a Clinical Professor of Pediatrics at a leading University School of Medicine and an Attending Pediatrician at a major Children's Hospital. In 1995, he launched DrGreene.com, cited by the American Medical Association as "the pioneer physician web site" on the Internet. Dr. Greene is also a regular columnist for Kiwi Magazine, as well as the author of "Raising Baby Green," "From First Kicks To First Steps," "The Parent's Complete Guide to Ear Infections," and a co-author of "The A.D.A.M. Illustrated Family Health Guide." About Twinlab:
Twinlab Corporation manufactures and markets more than 1200 different nutritional supplements. With offices in Manhattan, NY, Grand Rapids, MI, and American Fork, Utah, Twinlab is a leading producer of high quality, science-based nutritional products, including a complete line of sports nutrition, vitamins, minerals, nutraceuticals, herbs and tea products. About Vitamin Shoppe Industries Inc.
Vitamin Shoppe is a leading specialty retailer and direct marketer of nutritional products based in North Bergen, New Jersey. The company sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, and other health and beauty aids to customers located primarily in the United States. The company carries national brand products as well as exclusive products under Vitamin Shoppe, BodyTech, MD Select, and VS Basics proprietary brands. The Vitamin Shoppe conducts business through more than 360 company-owned retail stores, national mail order catalogs, and two websites, www.vitaminshoppe.com and www.Bodytech.com. CONTACT: (For ISI Brands) SSA Public Relations Steve Syatt Email Contact (818) 907-5929
(For TVS) Susan McLaughlin 201-624-3134 Email Contact
|